UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

How to Simplify the Evaluation of Newly Introduced Chemotherapeutic Interventions in Myeloma

Clinical hematology international, 2021-03, Vol.3 (1), p.27-33

2021

Volltextzugriff (PDF)

Mutation of CEBPA in Familial Acute Myeloid Leukemia

The New England journal of medicine, 2004-12, Vol.351 (23), p.2403-2407

2004

Volltextzugriff (PDF)

Long-term follow-up after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia/myelodysplastic syndrome: late CNS relapses despite graft-versus-host disease

Journal of clinical oncology, 2006-05, Vol.24 (14), p.e23-e25

2006

Volltextzugriff (PDF)

A novel K509I mutation of KIT identified in familial mastocytosis—in vitro and in vivo responsiveness to imatinib therapy

Leukemia research, 2006-04, Vol.30 (4), p.373-378

2006

Volltextzugriff (PDF)

Additional dexamethasone improves the response rate among patients with multiple myeloma treated with single agent bortezomib

Haematologica (Roma), 2006-07, Vol.91 (7), p.869B-869B

Cavenagh, Jamie D

2006

Volltextzugriff (PDF)

Thalidomide in multiple myeloma: current status and future prospects

British journal of haematology, 2003-01, Vol.120 (1), p.18-26

2003

Volltextzugriff (PDF)

Immune Biomarkers Identify Sustained Quantitative and Functional Immune Reconstitution in the Setting of Adjunctive Lenalidomide Following T-Depleted RIC-Allo SCT for Multiple Myeloma

Blood, 2016-12, Vol.128 (22), p.4585-4585

2016

Volltextzugriff (PDF)

Variable Penetrance Is Linked with Monoallelic Gene Expression in Inherited GATA2-Mutated MDS/AML

Blood, 2016-12, Vol.128 (22), p.3916-3916

2016

Volltextzugriff (PDF)

Vorinostat Does Not Improve Outcome in Patients with Acute Myeloid Leukemia and High Risk Myelodysplasia Treated with Azacitidine: Results of the UK Trials Acceleration Programme Ravva Trial

Blood, 2016-12, Vol.128 (22), p.1065-1065

2016

Volltextzugriff (PDF)

Factors which predict unsuccessful mobilisation of peripheral blood progenitor cells following G-CSF alone in patients with non-Hodgkin's lymphoma

The hematology journal : the official journal of the European Haematology Association, 2000, Vol.1 (6), p.367-373

2000

Volltextzugriff (PDF)

Panobinostat Plus Azacitidine in Adult Patients with MDS, CMML, or AML: Results of a Phase 2b Study

Blood, 2015-12, Vol.126 (23), p.2861-2861

2015

Volltextzugriff (PDF)

Changes in Mcl-1 and Bim Expression with Bortezomib and Melphalan Therapy for Multiple Myeloma

Blood, 2005-11, Vol.106 (11), p.2481-2481

2005

Volltextzugriff (PDF)

A Phase I/II Study of Bortezomib and Low Dose Intravenous Melphalan (BM) for Relapsed Multiple Myeloma

Blood, 2005-11, Vol.106 (11), p.2555-2555

2005

Volltextzugriff (PDF)

CD123 Expression in Chronic Lymphocytic Leukaemia - Strong Correlation with ZAP70 and CD38 Expression

Blood, 2004-11, Vol.104 (11), p.4406-4406

2004

Volltextzugriff (PDF)

Incidence of ZAP70 Positivity in Fresh Samples from Unselected Patients Presenting with a B-Cell Lymphoproliferative Disorder

Blood, 2004-11, Vol.104 (11), p.4399-4399

2004

Volltextzugriff (PDF)

Reduced Dose PAD Combination Therapy (PS-341/Bortezomib, Adriamycin and Dexamethasone) for Previously Untreated Patients with Multiple Myeloma

Blood, 2005-11, Vol.106 (11), p.2554-2554

2005

Volltextzugriff (PDF)

Flow Cytometric FLT3 Expression in Acute Leukaemias Is of Diagnostic Value but Does Not Correlate with ITD / D835Y Mutation Status

Blood, 2004-11, Vol.104 (11), p.3014-3014

2004

Volltextzugriff (PDF)

The White Cell

Medicine (Abingdon. 1995, UK ed.), 2000, Vol.28 (2), p.4-7

Cavenagh, Jamie D

2000

Volltextzugriff (PDF)

Development of original donor cell leukemia after successful engraftment from a second donor

Blood, 2007, Vol.110 (13), p.4621-4622

2007

Volltextzugriff (PDF)

Pre-Transplant NPM1 Mutant Transcript Level Is Highly Predictive of Outcome after Allograft and Thresholds Are Dependent on FLT3 ITD Status

Blood, 2018-11, Vol.132 (Supplement 1), p.2739-2739

2018

Volltextzugriff (PDF)

Patient-Reported Outcomes (PRO) in the Setting of Relapsed Myeloma: The Influence of Treatment Strategies and Genetic Variants Predict Quality of Life and Pain Experience

Blood, 2015-12, Vol.126 (23), p.3180-3180

2015

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(24)
Berichte
(1)

Sprache

Englisch
(25)
Japanisch
(1)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

How to Simplify the Evaluation of Newly Introduced Chemotherapeutic Interventions in Myeloma

Mutation of CEBPA in Familial Acute Myeloid Leukemia

Long-term follow-up after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia/myelodysplastic syndrome: late CNS relapses despite graft-versus-host disease

A novel K509I mutation of KIT identified in familial mastocytosis—in vitro and in vivo responsiveness to imatinib therapy

Additional dexamethasone improves the response rate among patients with multiple myeloma treated with single agent bortezomib

Thalidomide in multiple myeloma: current status and future prospects

Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trial

Immune Biomarkers Identify Sustained Quantitative and Functional Immune Reconstitution in the Setting of Adjunctive Lenalidomide Following T-Depleted RIC-Allo SCT for Multiple Myeloma

Variable Penetrance Is Linked with Monoallelic Gene Expression in Inherited GATA2-Mutated MDS/AML

Vorinostat Does Not Improve Outcome in Patients with Acute Myeloid Leukemia and High Risk Myelodysplasia Treated with Azacitidine: Results of the UK Trials Acceleration Programme Ravva Trial

Factors which predict unsuccessful mobilisation of peripheral blood progenitor cells following G-CSF alone in patients with non-Hodgkin's lymphoma

Final Analysis of Overall Survival from the First Trial

Panobinostat Plus Azacitidine in Adult Patients with MDS, CMML, or AML: Results of a Phase 2b Study

Changes in Mcl-1 and Bim Expression with Bortezomib and Melphalan Therapy for Multiple Myeloma

A Phase I/II Study of Bortezomib and Low Dose Intravenous Melphalan (BM) for Relapsed Multiple Myeloma

CD123 Expression in Chronic Lymphocytic Leukaemia - Strong Correlation with ZAP70 and CD38 Expression

Incidence of ZAP70 Positivity in Fresh Samples from Unselected Patients Presenting with a B-Cell Lymphoproliferative Disorder

Reduced Dose PAD Combination Therapy (PS-341/Bortezomib, Adriamycin and Dexamethasone) for Previously Untreated Patients with Multiple Myeloma

Flow Cytometric FLT3 Expression in Acute Leukaemias Is of Diagnostic Value but Does Not Correlate with ITD / D835Y Mutation Status

The White Cell

Development of original donor cell leukemia after successful engraftment from a second donor

Interaction between Presenting Features, Co-Occurring Mutations, MRD and Induction Treatment Influences Outcome in Adults with NPM1 Mutated AML - an Analysis of 1357 Patients in the UK NCRI AML17 and AML19 Studies

FLAG-Ida Combined with Gemtuzumab Ozogamicin (GO) Improves Event Free Survival in Younger Patients with Newly Diagnosed Acute Myeloid Leukaemia (AML) and Shows an Overall Survival Benefit in NPM1 and FLT3 mutated Subgroups. Results from the UK NCRI AML19 Trial

Pre-Transplant NPM1 Mutant Transcript Level Is Highly Predictive of Outcome after Allograft and Thresholds Are Dependent on FLT3 ITD Status

Patient-Reported Outcomes (PRO) in the Setting of Relapsed Myeloma: The Influence of Treatment Strategies and Genetic Variants Predict Quality of Life and Pain Experience

Aktive Filter

Suchergebnisse filtern